Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-10

Clinical Trial Update: Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma [EARLY_Phase 1]

View source ↗

Summary

Early phase 1 pilot study evaluating pazopanib with a low-fat meal in advanced renal cell carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pazopanib (Pazopanib)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Carcinoma, Renal Cell | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-06-10